Voyageur Pharmaceuticals Ltd. (VM.V)
CAD 0.11
(50.0%)
CAD 0.11
(50.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 10.32 Thousand CAD | 0.0% |
| 2022 | 10.32 Thousand CAD | 6.27% |
| 2021 | 9714.00 CAD | -1.7% |
| 2020 | 9882.00 CAD | -2.29% |
| 2019 | 10.11 Thousand CAD | 0.0% |
| 2018 | - CAD | 100.0% |
| 2017 | -75.28 Thousand CAD | -380.15% |
| 2016 | -15.68 Thousand CAD | -448.64% |
| 2015 | -2858.00 CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 10.32 Thousand CAD | 0.0% |
| 2024 Q1 | 10.32 Thousand CAD | 0.0% |
| 2024 Q3 | 10.32 Thousand CAD | 0.0% |
| 2023 Q2 | 10.32 Thousand CAD | 0.0% |
| 2023 Q3 | 10.32 Thousand CAD | 0.0% |
| 2023 Q4 | 10.32 Thousand CAD | 0.0% |
| 2023 FY | 10.32 Thousand CAD | 0.0% |
| 2023 Q1 | 10.32 Thousand CAD | 0.0% |
| 2022 Q3 | 9714.00 CAD | 0.0% |
| 2022 Q4 | 10.32 Thousand CAD | 6.27% |
| 2022 FY | 10.32 Thousand CAD | 6.27% |
| 2022 Q1 | 9714.00 CAD | 0.0% |
| 2022 Q2 | 9714.00 CAD | 0.0% |
| 2021 Q1 | 9682.00 CAD | -2.02% |
| 2021 Q2 | 9179.00 CAD | -5.2% |
| 2021 Q3 | 9591.00 CAD | 4.49% |
| 2021 Q4 | 9714.00 CAD | 1.28% |
| 2021 FY | 9714.00 CAD | -1.7% |
| 2020 Q3 | 10.11 Thousand CAD | 0.0% |
| 2020 Q2 | 10.11 Thousand CAD | 0.0% |
| 2020 Q1 | 10.11 Thousand CAD | 0.0% |
| 2020 FY | 9882.00 CAD | -2.29% |
| 2020 Q4 | 9882.00 CAD | -2.29% |
| 2019 Q2 | -81.51 Thousand CAD | -6.46% |
| 2019 FY | 10.11 Thousand CAD | 0.0% |
| 2019 Q4 | 10.11 Thousand CAD | 0.0% |
| 2019 Q3 | 10.11 Thousand CAD | 112.41% |
| 2019 Q1 | -76.56 Thousand CAD | 3.7% |
| 2018 Q3 | -53.9 Thousand CAD | 35.09% |
| 2018 Q1 | -79.52 Thousand CAD | -5.63% |
| 2018 FY | - CAD | 100.0% |
| 2018 Q4 | -79.5 Thousand CAD | -47.48% |
| 2018 Q2 | -83.04 Thousand CAD | -4.42% |
| 2017 Q3 | -53.25 Thousand CAD | -135.22% |
| 2017 FY | -75.28 Thousand CAD | -380.15% |
| 2017 Q4 | -75.28 Thousand CAD | -41.39% |
| 2017 Q1 | -18.06 Thousand CAD | -15.21% |
| 2017 Q2 | -22.63 Thousand CAD | -25.31% |
| 2016 FY | -15.68 Thousand CAD | -448.64% |
| 2016 Q3 | - CAD | 0.0% |
| 2016 Q2 | - CAD | 0.0% |
| 2016 Q4 | -15.68 Thousand CAD | 0.0% |
| 2016 Q1 | - CAD | 0.0% |
| 2015 Q4 | - CAD | 0.0% |
| 2015 Q2 | - CAD | 0.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2015 FY | -2858.00 CAD | 0.0% |
| 2015 Q3 | - CAD | 0.0% |
| 2014 Q4 | - CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 123.74 Thousand CAD | 91.658% |
| CanadaBis Capital Inc. | 5.82 Million CAD | 99.823% |
| Decibel Cannabis Company Inc. | 48.7 Million CAD | 99.979% |
| Delivra Health Brands Inc. | 1.47 Million CAD | 99.302% |
| Entourage Health Corp. | 10.01 Million CAD | 99.897% |
| Lifeist Wellness Inc. | 4.51 Million CAD | 99.771% |
| Cannara Biotech Inc. | 33.77 Million CAD | 99.969% |
| Medicure Inc. | 2.9 Million CAD | 99.644% |
| PharmaCielo Ltd. | 2.31 Million CAD | 99.553% |
| Rubicon Organics Inc. | 11.27 Million CAD | 99.908% |
| BioSyent Inc. | 5.89 Million CAD | 99.825% |